Delivery Order SPE2DB22D1202-SPE2DB23FHPN9

Award Date 5/15/23
Potential Completion Date 5/16/23
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,169.21, is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count quantities. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $1,049.48 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award, valued at $3,891.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as...
This federal contract award, with a ceiling value of $5,396.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,550,336 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRAJ2, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count quantities, with a ceiling value of $1,422.08. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,141.71, is for the delivery of 4,563,619,057 units of the prescription drug Pantoprazole Sodium Delayed Release 40 mg Tablets in quantities of 1,000. The contract has a firm fixed price and an ultimate completion date of February 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets. The contract has a ceiling value of $1,680.79 and is a Firm Fixed Price Delivery Order, with a period of performance through June 3, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
This federal contract award, with ID SPE2DB22D3016|SPE2DB23FBSW8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,792.08 Firm Fixed Price Delivery Order contract is for the supply of 4562252693 - Pantoprazole Sodium Delayed-Release 40 mg Tablets in 90-count packages. The contract has an ultimate completion date of September 21, 2023. This award is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,541.71 firm fixed-price delivery order is for the supply of 4,555,771,691 units of the pharmaceutical drug Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has a period of performance through December 23, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,725.94 firm-fixed-price delivery order is for the supply of 4,567,666,818 units of Pantoprazole Sodium Delayed-Release 40mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB23FHPN9
    Delivery Order

This federal contract award, valued at $2,219.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count units. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs.

Generated 5/9/25, 10:22 AM